WallStreetZenWallStreetZen

NASDAQ: ATXI
Avenue Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ATXI

Based on 1 analyst offering 12 month price targets for Avenue Therapeutics Inc.
Min Forecast
$0.75+410.2%
Avg Forecast
$0.75+410.2%
Max Forecast
$0.75+410.2%

Should I buy or sell ATXI stock?

Based on 1 analyst offering ratings for Avenue Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATXI stock forecasts and price targets.

ATXI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-11

1 of 1

ATXI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATXI$0.15$0.75+410.20%Strong Buy
BRTX$1.38N/AN/A
NLSP$0.18N/AN/A
VCNX$7.41N/AN/A
PULM$1.75N/AN/A

Avenue Therapeutics Stock Forecast FAQ

Is Avenue Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATXI) stock is to Strong Buy ATXI stock.

Out of 1 analyst, 1 (100%) are recommending ATXI as a Strong Buy, 0 (0%) are recommending ATXI as a Buy, 0 (0%) are recommending ATXI as a Hold, 0 (0%) are recommending ATXI as a Sell, and 0 (0%) are recommending ATXI as a Strong Sell.

If you're new to stock investing, here's how to buy Avenue Therapeutics stock.

What is ATXI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATXI price target, the average ATXI price target is $0.75, with the highest ATXI stock price forecast at $0.75 and the lowest ATXI stock price forecast at $0.75.

The Wall Street analyst predicted that Avenue Therapeutics's share price could reach $0.75 by Dec 11, 2024. The average Avenue Therapeutics stock price prediction forecasts a potential upside of 410.2% from the current ATXI share price of $0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.